The role of v2 receptor antagonists in the treatment of hyponatremia.
作者信息
Palmer Biff F
机构信息
Department of Internal Medicine, University of Texas Southwestern Medical Center, Korea.
出版信息
Electrolyte Blood Press. 2013 Jun;11(1):1-8. doi: 10.5049/EBP.2013.11.1.1. Epub 2013 Jun 30.
Abstract
摘要
相似文献
1
The role of v2 receptor antagonists in the treatment of hyponatremia.V2受体拮抗剂在低钠血症治疗中的作用。
Electrolyte Blood Press. 2013 Jun;11(1):1-8. doi: 10.5049/EBP.2013.11.1.1. Epub 2013 Jun 30.
2
The role of V2 vasopressin antagonists in hyponatremia.V2加压素拮抗剂在低钠血症中的作用。
Cardiovasc Res. 2001 Aug 15;51(3):403-8. doi: 10.1016/s0008-6363(01)00288-7.
3
Vasopressin V2-receptor antagonists: panaceas for hyponatremia?血管加压素V2受体拮抗剂：低钠血症的万灵药？
Curr Opin Nephrol Hypertens. 1997 Sep;6(5):461-7. doi: 10.1097/00041552-199709000-00009.
4
Treating hyponatremia in heart failure.治疗心力衰竭中的低钠血症。
Curr Cardiol Rep. 2006 May;8(3):204-10. doi: 10.1007/s11886-006-0035-9.
5
Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition.低钠血症与V2血管加压素受体上调：HSP90抑制的结果
Cancer Chemother Pharmacol. 2017 Oct;80(4):673-684. doi: 10.1007/s00280-017-3390-x. Epub 2017 Aug 4.
6
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.肝硬化、腹水和低钠血症患者的血管加压素 V2 受体拮抗剂。
Therap Adv Gastroenterol. 2012 May;5(3):189-97. doi: 10.1177/1756283X12437357.
7
[Vasopressin receptor antagonists: the vaptans].[血管加压素受体拮抗剂：血管加压素受体拮抗剂类药物]
Endocrinol Nutr. 2010 May;57 Suppl 2:41-52. doi: 10.1016/S1575-0922(10)70021-8.
8
Vasopressin-receptor antagonists.血管加压素受体拮抗剂
Future Cardiol. 2010 Jul;6(4):523-34. doi: 10.2217/fca.10.22.
9
New horizons in the pharmacologic approach to hyponatremia: the V2 receptor antagonists.低钠血症药物治疗的新视野：V2 受体拮抗剂。
J Hosp Med. 2010 Jul-Aug;5 Suppl 3:S27-32. doi: 10.1002/jhm.785.
10
New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia.血管加压素受体新课题及新型药物研发途径：治疗低钠血症药物盐酸考尼伐坦（YM087）的研究与开发
J Pharmacol Sci. 2009 Jan;109(1):53-9. doi: 10.1254/jphs.08r17fm.
引用本文的文献
1
Cisplatin-Induced Acute Kidney Injury and Renal Salt Wasting Syndrome.顺铂诱导的急性肾损伤和肾失盐综合征
Fed Pract. 2021 Dec;38(12):606-611a. doi: 10.12788/fp.0198. Epub 2021 Dec 12.
2
Duloxetine and Angiotensin II Receptor Blocker Combination Potentially Induce Severe Hyponatremia in an Elderly Woman.度洛西汀与血管紧张素 II 受体阻滞剂联用可能致一名老年女性发生严重低钠血症。
Intern Med. 2019 Jun 15;58(12):1791-1794. doi: 10.2169/internalmedicine.2059-18. Epub 2019 Feb 25.
3
Tolvaptan Use to Treat SIADH in a Child.托伐普坦用于治疗儿童抗利尿激素分泌异常综合征
J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):494-498. doi: 10.5863/1551-6776-23.6.494.
4
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?血管加压素V2受体拮抗剂对顽固性腹水的肝硬化患者有益吗？
World J Gastroenterol. 2015 Nov 7;21(41):11584-96. doi: 10.3748/wjg.v21.i41.11584.
5
Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?重度低钠血症的治疗：输注高渗盐水和去氨加压素还是输注血管加压素抑制剂？
Am J Med Sci. 2014 Nov;348(5):432-9. doi: 10.1097/MAJ.0000000000000331.
本文引用的文献
1
Oral tolvaptan is safe and effective in chronic hyponatremia.口服托伐普坦治疗慢性低钠血症安全有效。
J Am Soc Nephrol. 2010 Apr;21(4):705-12. doi: 10.1681/ASN.2009080857. Epub 2010 Feb 25.
2
Impact of hospital-associated hyponatremia on selected outcomes.医院获得性低钠血症对特定结局的影响。
Arch Intern Med. 2010 Feb 8;170(3):294-302. doi: 10.1001/archinternmed.2009.513.
3
Hyponatremia independent of osteoporosis is associated with fracture occurrence.非骨质疏松性低钠血症与骨折发生有关。
Clin J Am Soc Nephrol. 2010 Feb;5(2):275-80. doi: 10.2215/CJN.06120809. Epub 2010 Jan 7.
4
Conivaptan and its role in the treatment of hyponatremia.考尼伐坦及其在低钠血症治疗中的作用。
Drug Des Devel Ther. 2009 Dec 29;3:253-68. doi: 10.2147/dddt.s4505.
5
Hyponatremia-induced osteoporosis.低钠血症性骨质疏松症。
J Bone Miner Res. 2010 Mar;25(3):554-63. doi: 10.1359/jbmr.090827.
6
Mortality after hospitalization with mild, moderate, and severe hyponatremia.轻度、中度和重度低钠血症住院后的死亡率。
Am J Med. 2009 Sep;122(9):857-65. doi: 10.1016/j.amjmed.2009.01.027.
7
The treatment of hyponatremia.低钠血症的治疗。
Semin Nephrol. 2009 May;29(3):282-99. doi: 10.1016/j.semnephrol.2009.03.002.
8
Hyponatremia in the intensive care unit.重症监护病房中的低钠血症
Semin Nephrol. 2009 May;29(3):257-70. doi: 10.1016/j.semnephrol.2009.03.003.
9
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH).抗利尿激素分泌不当综合征（SIADH）
Semin Nephrol. 2009 May;29(3):239-56. doi: 10.1016/j.semnephrol.2009.03.005.
10
Regulation of aquaporin-2 trafficking.水通道蛋白-2转运的调节
Handb Exp Pharmacol. 2009(190):133-57. doi: 10.1007/978-3-540-79885-9_6.
Zotero 插件